Press release
HIV-AIDS Testing Market Plying for Significant Growth by 2020
To View Complete Report @ : http://www.persistencemarketresearch.com/market-research/hiv-aids-testing-market.asp
Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue. HIV-AIDS has no cure but there are treatments which help to reduce AIDS deaths. HIV-AIDS can be treated by nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor. Some of the drugs for HIV -AIDS treatment include atripla, epzicom, prezista, truvada, kaletra, isentress, reyataz and viread. HIV testing and diagnostics include early detection, treatment swatching, On the basis of diagnosis HIV-AIDS market can be classified into HIV antibody assay, western blot, antigen-antibody immunoassay, HIV home-testing kit, rapid HIV antibody test, polymerase chain reaction test and HIV p24 antigen test.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3270
Europe, followed by North America, has the largest market for HIV-AIDS testing due to affordability and accessibility of expensive tests for HIV-AIDS and innovations in drug therapies in this region. Asia is expected to show high growth rate in the HIV-AIDS testing market in next few years due to increasing number of HIV-AIDS population and increasing research activities for developing HIV drugs and vaccines in the region.
Increasing number of HIV patients, technological advancement in HIV-AIDS diagnosis, increasing incidence of infectious diseases, rise in research activities for developing HIV vaccines and lack of awareness about the modes of transmission of the virus are expected to drive the market for HIV-AIDS testing. In addition, increasing awareness about HIV aids treatment options available in the market and cost effective drug therapies for HIV is expected to drive the HIV-AIDS testing market. However, rapid replacement of HIV-AIDS drugs and therapies by new drugs and therapies and patient protection losses are some of the factors restraining the growth for global HIV-AIDS testing market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3270
Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in HIV-AIDS testing market in Asia. In addition, rise in awareness about HIV-AIDS treatment and innovations in technologies related to HIV-AIDS testing are expected to offer new opportunity to global HIV-AIDS testing market. Companies involved in new product launch is one the recent trends have been observed in global HIV-AIDS testing market. Some of the major companies operating in the global HIV AIDS market are Abbott Laboratories Inc., Hologic Inc., Siemens Healthcare Diagnostics Inc., Bio-Rad Laboratories Inc., Roche Diagnostics Inc. and Ortho-Clinical Diagnostics Inc.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV-AIDS Testing Market Plying for Significant Growth by 2020 here
News-ID: 654339 • Views: …
More Releases from Persistence Market Research
Global Warehouse Management Systems Market to Reach US$12.5 Bn by 2032
The global warehouse management systems (WMS) market is projected to grow from US$4.7 billion in 2025 to US$12.5 billion by 2032, registering a CAGR of 15.1%. The rapid growth of e-commerce, globalization of supply chains, and increasing demand for real-time inventory tracking are key drivers fueling this market. WMS software plays a critical role in streamlining warehouse operations, from receiving goods to shipping, ensuring accuracy, efficiency, and reduced operational costs.
North…
Global Home Security Systems Market to Reach US$ 76.9 Bn by 2032
The global home security systems market is projected to grow from US$47.6 billion in 2025 to US$76.9 billion by 2032, registering a CAGR of 7.2%. Increasing crime rates, rising property thefts, and growing urbanization are key factors driving demand for smarter and safer living environments. Both homeowners and businesses are seeking advanced security solutions that provide real-time monitoring, greater control, and enhanced protection against burglary, fire, and other threats.
North America…
Global Cargo Management Tech Market to Reach $11.4 Bn by 2032
The global cargo management technology solutions market is projected to grow from US$3.7 billion in 2025 to US$11.4 billion by 2032, registering a robust CAGR of 17.5%. The growth is fueled by the rapid expansion of e-commerce, increasing international trade, and rising demand for efficient logistics systems capable of handling large order volumes while ensuring timely deliveries. Businesses are increasingly seeking solutions that enhance operational efficiency, streamline supply chain processes,…
Digital Rights Management Market Trends and Growth Analysis 2025-2032
The global digital rights management (DRM) market is poised for significant growth, with its size expected to reach US$11.6 billion by 2032, up from US$5.5 billion in 2025, registering a robust CAGR of 11.2%. The increasing adoption of digital content across media, entertainment, and enterprise sectors has accelerated the demand for effective content protection solutions. As intellectual property rights become a focal point for businesses and consumers alike, the need…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
